Bruno Farmaceutici S.p.A.

Industry

  • Pharmaceuticals
    • OTC, Consumer
    • Nutraceuticals

Other Names/Subsidiaries

  • Safilens
See more in Biomedtracker

Latest on Bruno Farmaceutici S.p.A.

Scrip

Deal Watch: Genentech Expands Upon Arvinas PROTAC Collaboration

 
• By Joseph Haas, Ying Huang, and Alex Shimmings

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Scrip

Deal Watch: GSK Declines Option As Ionis' Inotersen Nears Finish Line

 
• By Joseph Haas, Anju Ghangurde, and Lubna Ahmed

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

In Vivo

Deals Shaping The Medical Industry, April 2017

 
• By Beth Allan, Steven Muntner, Deanna Kamienski, Maureen Riordan, and Amanda Micklus

IN VITRO DIAGNOSTICS Financings Biocept Inc. Biocept Inc. (blood-based molecular diagnostics for solid tumors) netted $8.7mm through the sale of 4.3mm common shares at $2.15 (a slight discount) to

Scrip

Deal Watch: Merck, Incyte Double Down On Keytruda/Epacadostat Collaboration

 
• By Joseph Haas and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions that occurred from March 27-31. Dea